Agbaje Lateef | Nanobiotechnology | Outstanding Scientist Award

Prof. Agbaje Lateef | Nanobiotechnology | Outstanding Scientist Award

Professor | Ladoke Akintola University of Technology (LAUTECH) | Nigeria

Prof. Agbaje Lateef is a globally recognized scholar in Industrial Microbiology, Biotechnology, and Nanobiotechnology, distinguished for his pioneering contributions to green nanotechnology and microbial valorization. With an exceptional research impact reflected in over 5,201 Scopus citations, 128 documents, 46 h-index, more than 160 peer-reviewed publications, influential book contributions, and multiple editorial roles, he ranks among the top 2% scientists globally (Elsevier–Stanford). His research has significantly advanced biogenic synthesis of metallic and metal-oxide nanoparticles, establishing cost-effective, eco-friendly approaches using microbial systems, agro-wastes, enzymes, and plant-based materials. These innovations contribute to diverse applications spanning biomedicine, environmental remediation, agriculture, water treatment, catalysis, and circular bioeconomy. He has demonstrated impactful findings on nanoparticle-enabled antimicrobial, antioxidant, anticancer, anticoagulant, larvicidal, antidiabetic, and nanofertilizer functions, offering transformative solutions for health, agriculture, and industry. A leading figure in Nigeria’s nanotechnology landscape, Prof. Agbaje Lateef is the Head of the Nanotechnology Research Group (NANO+), which has produced high-impact research outputs and consistently hosted national workshops and conferences since 2017. His scientometric studies have mapped Nigeria’s nanotechnology progress, shaping national visibility and research direction. His scholarly contributions include serving as Lead Editor of the authoritative book Microbial Nanobiotechnology: Principles and Applications (Springer, 2021), and co-editor of Microbiome and Nano-Cross-Talk: Sustainable Agriculture and Beyond (Elsevier, 2024). He has developed novel nanomaterials for wastewater treatment, corrosion inhibition, biomedical applications, and enhanced crop productivity. Prof. Agbaje Lateef’s work is supported by competitive national research grants, enabling breakthroughs in valorization of keratinous wastes, nanobiopesticides, nano-enabled aquaculture, and nanoparticle-mediated disease management. His research recognitions include prestigious awards for scholarly excellence and sustained global impact. He also provides extensive service as reviewer, editorial board member, and contributor to high-impact journals. Prof. Agbaje Lateef stands as a leading voice in advancing sustainable nanobiotechnology and shaping the future of microbial-based nanomaterial innovation.

Profiles: Scopus | ORCID | Google Scholar | ResearchGate | Web of Science | ScholarGPS | Exaly | Research Group Website 

Featured Publications

1. Adelere, I. A., & Lateef, A. (2016). A novel approach to the green synthesis of metallic nanoparticles: The use of agro-wastes, enzymes and pigments. Nanotechnology Reviews, 5(6), 567–587. https://doi.org/10.1515/ntrev-2016-0024

2. Lateef, A., Azeez, M. A., Asafa, T. B., Yekeen, T. A., Akinboro, A., Oladipo, I. C., Azeez, L., Ajibade, S. E., Ojo, S. A., Gueguim-Kana, E. B., & Beukes, L. S. (2016). Biogenic synthesis of silver nanoparticles using a pod extract of Cola nitida: Antibacterial, antioxidant activities and application as a paint additive. Journal of Taibah University for Science, 10(4), 551–562. https://doi.org/10.1016/j.jtusci.2015.10.010

3. Lateef, A., Adelere, I. A., Gueguim-Kana, E. B., Asafa, T. B., & Beukes, L. S. (2015). Green synthesis of silver nanoparticles using keratinase obtained from a strain of Bacillus safensis LAU 13. International Nano Letters, 5(1), 29–35. https://doi.org/10.1007/s40089-014-0133-4

4. Gueguim Kana, E. B., Oloke, J. K., Lateef, A., & Adesiyan, M. O. (2012). Modeling and optimization of biogas production on saw dust and other co-substrates using artificial neural network and genetic algorithm. Renewable Energy, 46, 276–281. https://doi.org/10.1016/j.renene.2012.03.027

5. Lateef, A., Oloke, J. K., Gueguim Kana, E. B., Oyeniyi, S. O., Onifade, O. R., Oyeleye, A. O., Oladosu, O. C., & Oyelami, A. O. (2008). Improving the quality of agro-wastes by solid-state fermentation: Enhanced antioxidant activities and nutritional qualities. Biotechnology Letters, 24, 2369–2374. https://doi.org/10.1007/s10529-008-9795-4

Muneeb Ullah | Nanobiotechnology | Best Paper Award

Mr. Muneeb Ullah | Nanobiotechnology | Best Paper Award

PhD Student | Pusan National University | South Korea

Mr. Muneeb Ullah is an accomplished nanomedicine researcher specializing in pharmaceutical nanotechnology, drug delivery systems, and biomaterials for therapeutic applications. His research primarily focuses on the synthesis and characterization of nanoparticles for wound healing, colorectal cancer, diabetic wound treatment, and inflammatory bowel diseases. He has published 38 scientific documents with 504 citations and an h-index of 11, reflecting strong and consistent contributions to high-impact biomedical research. Mr. Muneeb Ullah has authored numerous peer-reviewed journal papers and book chapters in leading outlets such as Chemical Engineering Journal, Small, Carbohydrate Polymer Technologies & Applications, European Polymer Journal, Journal of Pharmaceutical Investigation, and Current Problems in Cardiology. His works have collectively accumulated an impressive total impact factor exceeding 120. His notable contributions include advancements in nanoparticle-based therapeutics, 3D and 4D bioprinting, nanocarbon-based biomedical materials, and smart wound-healing systems. He has also co-authored multiple academic books and chapters published by CRC Press and Academic Press, covering topics such as fungal biotechnology, gastrointestinal inflammation, carbon dots, cancer nanomedicine, and nanotechnology in wound healing. His interdisciplinary collaborations have led to innovations in biofilm-associated therapies, tissue engineering, and targeted drug delivery systems. Recognized as a Best Researcher Award recipient in 2024 and 2025, Mr. Muneeb Ullah’s scholarly impact extends to editorial and reviewer services for international journals. His ongoing projects explore novel nanocluster adhesives, biopolymer-based nanostructures, and tumor-selective delivery mechanisms. Through his pioneering R&D initiatives, Mr. Muneeb Ullah continues to advance the frontiers of nanomedicine, combining pharmaceutical technology with molecular innovation to address complex biomedical challenges globally.

Profiles: Scopus | ResearchGate | Sci Profiles | Scholar GPS

Featured Publications

1. Safdar, M., Ullah, M., Hamayun, S., Wahab, A., Khan, S. U., Abdikakhorovich, S. A., Haq, Z. U., Mehreen, A., Naeem, M., Mustopa, A. Z., & Hasan, N. (2024). Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease. Current Problems in Cardiology, 49(9), 102686. https://doi.org/10.1016/j.cpcardiol.2024.102686

2. Khan, M. A., Khan, N., Ullah, M., Hamayun, S., Makhmudov, N. I., Mbbs, R., Safdar, M., Bibi, A., Wahab, A., Naeem, M., & Hasan, N. (2024). 3D printing technology and its revolutionary role in stent implementation in cardiovascular disease. Current Problems in Cardiology, 49(6), 102568. https://doi.org/10.1016/j.cpcardiol.2024.102568

3. Khan, S. U., Ullah, M., Saeed, S., Saleh, E. A. M., Kassem, A. F., Arbi, F. M., Wahab, A., Rehman, M., ur Rehman, K., Khan, D., … & Lu, K. (2024). Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications. European Polymer Journal, 207, 112819. https://doi.org/10.1016/j.eurpolymj.2024.112819

4. Khan, S. U., Huang, Y., Ali, H., Ali, I., Ahmad, S., Khan, S. U., Hussain, T., Ullah, M., & Lu, K. (2024). Single-cell RNA sequencing (scRNA-seq): Advances and challenges for cardiovascular diseases (CVDs). Current Problems in Cardiology, 49(2), 102202. https://doi.org/10.1016/j.cpcardiol.2023.102202

5. Zeb, F., Mehreen, A., Naqeeb, H., Ullah, M., Waleed, A., Awan, U. A., Haider, A., & Naeem, M. (2024). Nutrition and dietary intervention in cancer: Gaps, challenges, and future perspectives. In Nutrition and Dietary Interventions in Cancer (pp. 281–307). Springer Nature Switzerland. https://doi.org/10.1007/978-3-031-55622-7_11

David Stejskal | Nanobiotechnology | Best Researcher Award

Prof. Dr. David Stejskal | Nanobiotechnology | Best Researcher Award

Professor, MD, PhD, MBA, EuSpLM, Head of the Institute of Laboratory Medicine | University Hospital in Ostrava | Czech Republic

Prof. Dr. David Stejskal, MD, PhD, MBA, EuSpLM, is a distinguished researcher and academic leader in the field of laboratory medicine, clinical biochemistry, and internal medicine. His research primarily focuses on the identification and clinical validation of novel biomarkers relevant to metabolic, cardiovascular, nephrological, and inflammatory diseases. With over 3,767 citations, an h-index of 29 (Scopus), and more than 200 peer-reviewed publications, his scholarly influence spans translational diagnostics and clinical applications in metabolic and endocrine disorders. His most cited works include pioneering studies on fatty acid binding proteins (FABP), chemerin, and FGF23, which have significantly advanced understanding of biomarkers in metabolic syndrome, chronic kidney disease, and cardiovascular risk assessment. Prof. Dr. David Stejskal’s research group has also contributed substantially to the development of novel diagnostic markers for diabetes, obesity, and atherosclerosis, as well as the evaluation of inflammatory and oxidative stress parameters in internal medicine. Beyond journal publications, he has authored and co-authored several scientific books such as Metabolic Diseases of Mass Incidence, Dyslipidemia, and Urolithiasis, alongside chapters in specialized medical encyclopedias. His work has been instrumental in shaping biomarker-based diagnostic strategies across Central Europe. Prof. Dr. David Stejskal has received notable research and organizational recognitions, including the OMICS Award (USA) for excellence in translational medicine and the Czech Society of Clinical Biochemistry Award. As an editorial contributor, reviewer, and conference organizer, he has significantly influenced international collaboration in laboratory and clinical research. His continued focus on biochemical innovation, diagnostic optimization, and translational research highlights his contribution to advancing laboratory medicine and evidence-based clinical diagnostics globally.

Profiles: Scopus | ORCID | ResearchGate | Sci Profiles | Web of Science

Featured Publications

1. Sigutova, R., Evin, L., Kusnierova, P., Svagera, Z., Branny, M., & Vaclavik, J. (2025). Specific microRNAs for heart failure: Reference values in whole blood. Biomedicines, 13(10), 2559. https://doi.org/10.3390/biomedicines13102559

2. Urinovska, R., Sistik, P., Buzga, M., & Stejskal, D. (2024). Fast and easy simultaneous determination of riboflavin, folic acid, all-trans-retinol and α-tocopherol in human serum by LC/MS/MS for bariatric patients. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmae035

3. Johannsen, B., Baumgartner, D., Karpíšek, M., Paust, N., Zengerle, R., & Mitsakakis, K. (2024). Integration of a bead-based immunoassay on a commercial PCR-performing POC device. Proceedings, 2024(097166). https://doi.org/10.3390/proceedings2024097166

4. Johannsen, B., Baumgartner, D., Karpíšek, M., Paust, N., Zengerle, R., & Mitsakakis, K. (2023). Patient stratification for antibiotic prescriptions based on the bound-free phase detection immunoassay of C-reactive protein in serum samples. Biosensors, 13(12), 1009. https://doi.org/10.3390/bios13121009

5. Plášek, J., Lazárová, M., Dodulík, J., Švagera, Z., Všianský, F., & Václavík, J. (2022). Secretoneurin as a novel biomarker of cardiovascular episodes: Are we there yet? A narrative review. Journal of Clinical Medicine, 11(23), 7191. https://doi.org/10.3390/jcm11237191